Rapid Micro Biosystems, Inc. filings document the company's microbial quality-control automation business, governance matters and capital structure. Form 8-K reports furnish operating results, preliminary revenue updates, Regulation FD disclosures about the Growth Direct platform, and material agreements such as term-loan financing secured by company assets and related warrants for Class A common stock.
Proxy filings cover annual meeting procedures, stockholder voting matters, board governance and executive compensation disclosures. Other material-event reports address officer-transition and compensatory-arrangement disclosures, while recent cover pages identify the company as an emerging growth company for Exchange Act reporting purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.30%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.88%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
FAQ
How many RAPID MICRO BIOSYSTEMS (RPID) SEC filings are available on StockTitan?
StockTitan tracks 73 SEC filings for RAPID MICRO BIOSYSTEMS (RPID), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for RAPID MICRO BIOSYSTEMS (RPID)?
The most recent SEC filing for RAPID MICRO BIOSYSTEMS (RPID) was filed on July 10, 2025.